Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral

This study underscores the potential of dRT as a feasible strategy for deferring systemic therapy escalation in patients with oligometastatic and oligoprogressive metastatic thyroid cancer, demonstrating that sequential dRT courses impart excellent local control and are safe to deliver repeatedly for multiple distant sites. Further studies are warranted to validate these findings and elucidate the full benefit of dRT as part of a multidisciplinary approach for metastatic thyroid cancer.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2024-12-11
DOI
https://doi.org/10.6004/jnccn.2024.7072
Citations
5
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral

Jack Phan, Sarah Hamidi, Joe Y. Chang, Mark Zafereo et al.
5 citations
Journal of the National Comprehensive Cancer Network
Thyroid Cancer Diagnosis and Treatment
1.79
article

Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral

Jack Phan, Sarah Hamidi, Joe Y. Chang, Mark Zafereo, James Welsh, G. Brandon Gunn, Ethan B. Ludmir, Vicente Rodrigues Marczyk, Matthew S. Ning, Stephanie O. Dudzinski, Steven Gerard Waguespack, Aileen B. Chen, Naifa Lamki Busaidy, Anita K. Ying, Steven Hsesheng Lin, Jay P. Reddy, Thomas Hendrix Beckham, Ramona Dadu, Mimi I-Nan Hu, Steven I. Sherman, Maria E. Cabanillas, Zhongxing Liao, Anna Lee, Michael S. O’Reilly, Quynh-Nhu Nguyen, Saumil Gandhi, Chenyang Wang
article en
5 citations

Abstract

This study underscores the potential of dRT as a feasible strategy for deferring systemic therapy escalation in patients with oligometastatic and oligoprogressive metastatic thyroid cancer, demonstrating that sequential dRT courses impart excellent local control and are safe to deliver repeatedly for multiple distant sites. Further studies are warranted to validate these findings and elucidate the full benefit of dRT as part of a multidisciplinary approach for metastatic thyroid cancer.

Journal of the National Comprehensive Cancer NetworkVol. 23(1)
The University of Texas MD Anderson Cancer Center (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 13%
Thyroid Cancer Diagnosis and Treatment
1.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.